Greenwich LifeSciences (GLSI) Assets (2019 - 2026)

Greenwich LifeSciences (GLSI) has 7 years of Assets data on file, last reported at $6.2 million in Q4 2025.

• Quarterly Assets rose 50.91% year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.2 million (up 50.91% YoY) and the FY2025 annual result came in at $6.2 million, up 50.91% from the prior year.
• Assets advanced to $6.2 million in Q4 2025, from $3.8 million in the prior quarter.
• In the past five years, Assets ranged from a high of $30.4 million in Q1 2021 to a low of $2.8 million in Q1 2025.
• A 5-year average of $13.0 million and a median of $10.1 million in 2023 frame the typical range for Assets.
• Annual changes were most pronounced in 2021 — Assets jumped 360.94% — and 2025, when it sank 56.77%.
• Tracing GLSI's Assets over 5 years: stood at $27.2 million in 2021, then plunged by 50.48% to $13.5 million in 2022, then sank by 48.1% to $7.0 million in 2023, then sank by 41.47% to $4.1 million in 2024, then soared by 50.91% to $6.2 million in 2025.
• The last three Assets figures came in at $6.2 million (Q4 2025), $3.8 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.